Načítá se...
Combination Therapy Against Indian Visceral Leishmaniasis with Liposomal Amphotericin B (Fungisome(TM)) and Short-Course Miltefosine in Comparison to Miltefosine Monotherapy
Visceral leishmaniasis (VL) is endemic in Asia, East and North Africa, South America, and Southern Europe, and is a major public health problem in the Indian subcontinent. Miltefosine received approval in 2002 to treat VL in India, and the Indian National Vector Borne Disease Control Programme later...
Uloženo v:
| Vydáno v: | Am J Trop Med Hyg |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society of Tropical Medicine and Hygiene
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356435/ https://ncbi.nlm.nih.gov/pubmed/32394874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0931 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|